Results 21 to 30 of about 361,832 (264)

Increasing the uptake of vitamin D supplement use in Australian residential aged care facilities: results from the vitamin D implementation (ViDAus) study

open access: yesBMC Geriatrics, 2020
Background Adequate (≥800 IU/day) vitamin D supplement use in Australian residential aged care facilities (RACFs) is variable and non-optimal. The vitamin D implementation (ViDAus) study aimed to employ a range of strategies to support the uptake of this
Pippy Walker   +3 more
doaj   +1 more source

Psychotropic medications in older people in residential care facilities and associations with quality of life: a cross-sectional study

open access: yesBMC Geriatrics, 2018
Background Psychotropic medications have been associated with many adverse outcomes in older people living in residential care. Home-like models of residential care may be preferable to traditional models of care and we hypothesized that this model may ...
Stephanie L. Harrison   +6 more
doaj   +1 more source

Impacts of baseline biomarkers on cognitive trajectories in subjective cognitive decline: the CoSCo prospective cohort study

open access: yesAlzheimer’s Research & Therapy, 2023
Background Subjective cognitive decline (SCD) is a risk factor for Alzheimer’s disease (AD); however, the rates of cognitive decline are variable according to underlying pathologies and biomarker status.
Yun Jeong Hong   +8 more
doaj   +1 more source

Steeper memory decline after COVID-19 lockdown measures

open access: yesAlzheimer’s Research & Therapy, 2023
Background During COVID-19 lockdown measures, memory clinic patients reported worries for faster cognitive decline, due to loss of structure and feelings of loneliness and depression. We aimed to investigate the impact of the COVID-19 lockdown on rate of
Els D. Bakker   +7 more
doaj   +1 more source

Subjective cognitive decline as a predictor of future cognitive decline: a systematic review

open access: yesDementia & Neuropsychologia, 2020
. Over 44 million people suffer from dementia around the world. Researchers estimated that there will be 48.1 million people with dementia by 2020 and 90.3 million by 2040. In addition to dementia, mild cognitive impairment (MCI) and subjective cognitive
Vladimir Anatolevich Parfenov   +3 more
doaj   +1 more source

Cognition Enhancers in Age-Related Cognitive Decline [PDF]

open access: yesDrugs & Aging, 1996
A review of recently published studies on the effect of cognition enhancers in non-demented human study participants is presented. The heterogeneity of the therapeutic target, age-associated cognitive decline, can be improved by separately treating groups in whom age-extrinsic factors may underlie cognitive pathology.
Riedel, Wim J., Jolles, Jellemer
openaire   +3 more sources

Protocol for a non-randomised pilot and feasibility study evaluating a multicomponent intervention to simplify medication regimens for people receiving community-based home care services

open access: yesBMJ Open, 2019
Introduction Managing medication regimens is one of the most complex and burdensome tasks performed by older people, and can be prone to errors. People living with dementia may require medication administration assistance from formal and informal ...
Sarah N Hilmer   +10 more
doaj   +1 more source

Cognition: The brain's decline [PDF]

open access: yesNature, 2012
Treating cognitive problems common in elderly people requires a deeper understanding of how a healthy brain ages.
openaire   +2 more sources

Longitudinal associations between physical and cognitive performance among community-dwelling older adults. [PDF]

open access: yesPLoS ONE, 2015
To assess the directionality of the association between physical and cognitive decline in later life, we compared patterns of decline in performance across groups defined by baseline presence of cognitive and/or physical impairment [none (n = 217 ...
Magdalena I Tolea   +2 more
doaj   +1 more source

Isolated Cognitive Decline in Neurologically Stable Patients with Multiple Sclerosis

open access: yesDiagnostics, 2021
(1) Background: Cognitive deterioration is an important marker of disease activity in multiple sclerosis (MS). It is vital to detect cognitive decline as soon as possible. Cognitive deterioration can take the form of isolated cognitive decline (ICD) with
Jiri Motyl   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy